Bruckner’s biopharma and medtech strategists are dedicated to making clinical-stage therapeutics, diagnostics, devices, and wearables succeed. And no one else does it quite the way we do. Call us rebels, but we’re not exactly big fans of the industry’s prevailing development process. It leads to diminished value and far too many unnecessary failures. In fact, if there’s one thing we’ve learned from our 20 years in the trenches, it’s this: Conformity is the refuge of the uninspired. That’s why we made it our mission in life to implement an entirely new construct.

And the result is a data-driven, integrated, multi-dimensional approach to strategy development that reveals what others routinely miss. In other words, we find what our clients need to know.  And what they need to do. Truth is, by viewing clinical development possibilities through such a discriminating lens, we’re able to totally transform our clients’ clinical programs. Which, to our way of thinking, is the best way to provide enduring value. And, perhaps more importantly, to make a positive impact on the entire healthcare system.


Uncommon solutions to common problems

Serving clients from big pharma to start-ups and VCs across all disease areas and sub-specialties. Our innovative processes result in strategic and tactical solutions to your most pressing needs.

Clinical program and new product development

  • Disease area/indication determination, prioritization, and roll-out
  • Clinical development pathway and trial optimization
  • Value proposition development and maximization across all stakeholder needs
  • Exit design and incorporation

Stakeholder engagement and strategy

  • Pressure-testing therapeutic value propositions, to determine how payers will react
  • Payer strategy and market access
  • Regulatory strategy
  • Strategic incorporation of early-commercialization functions

Corporate-level strategy, management, and operations

  • Development of scientific and operational competitive advantage
  • Rationalization and augmentation of the development pipeline
  • Development of strategic alliances
  • Corporate development, partnering, financing

Read More


Of Clinical Stage Drug Fail.


Strategies that work

Find out how The Bruckner Group can help you build an optimized pathway to success with measurable results for your organization.

Contact us to learn more.

Let's Talk